ARESTIN® promotes a healthier oral environment - long after your patient leaves your office - so healing can begin
Sustains a healthier balance of bacteria for 30 days
ARESTIN® delivers minocycline directly to infected pockets, providing safe, localized drug concentrations at the site of the infection. ARESTIN® stays in place and provides reduced bacterial levels, measurable even 30 days after treatment.
- ARESTIN® maintains minimum inhibitory concentration (MIC) levels well above those required for common periodontal pathogens for up to 21 days.
- Clinical trials show the use of ARESTIN® did not result in a significant increase of minocycline-resistant bacteria 2 months posttreatment.
Concentrations of minocycline in gingival crevicular fluid (GCF) at the site of administration
In susceptible individuals, the ongoing inflammatory process without intervention can cause loss of supporting tissue and, ultimately, teeth.
- A persistent, active infection that can spread rapidly throughout the periodontium—it is caused by the presence of Gram-negative bacteria
- The most common chronic bacterial infection in adults
- The leading cause of adult tooth loss in the U.S.
For full safety information, click here.
